Prof. Marta Weinstock-Rosin of the School of Pharmacy in the Faculty of Medicine developed Exelon, a medicine prescribed for people with mild to moderate Alzheimer's disease. Exelon can slow the progression of the disease in a significant proportion of patients and improve cognitive function in some subjects. Exelon is manufactured by Novartis (Switzerland). January 19, 2012. Photo by Nati Shohat/Flash90